CLINICAL_TRIALS
trial_result
· 2022-02-10
Clinical Trial Update: CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF) [NA]
Summary
A completed clinical trial (CONVERGE) evaluating epicardial/endoablation for persistent atrial fibrillation; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AtriCure, Inc. | Conditions: Persistent Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2022-02-10